Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-24-003375
Filing Date
2024-05-14
Accepted
2024-05-14 13:47:19
Documents
55
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q FOR 3/31/24 mosaic_i10q-033124.htm   iXBRL 10-Q 620452
2 UNSECURED CONVERTIBLE NOTE PURCHASE AGREEMENT DATED MAY 8, 2024 mosaic_ex1002.htm EX-10.2 86488
3 CERTIFICATION mosaic_ex3101.htm EX-31.1 8395
4 CERTIFICATION mosaic_ex3102.htm EX-31.2 8319
5 CERTIFICATION mosaic_ex3201.htm EX-32.1 4704
6 CERTIFICATION mosaic_ex3202.htm EX-32.2 4857
  Complete submission text file 0001683168-24-003375.txt   3115079

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE cpmv-20240331.xsd EX-101.SCH 27984
8 XBRL CALCULATION FILE cpmv-20240331_cal.xml EX-101.CAL 33634
9 XBRL DEFINITION FILE cpmv-20240331_def.xml EX-101.DEF 113816
10 XBRL LABEL FILE cpmv-20240331_lab.xml EX-101.LAB 227723
11 XBRL PRESENTATION FILE cpmv-20240331_pre.xml EX-101.PRE 200688
59 EXTRACTED XBRL INSTANCE DOCUMENT mosaic_i10q-033124_htm.xml XML 252135
Mailing Address 9114 ADAMS AVE. #202 HUNTINGTON BEACH CA 92646
Business Address 9114 ADAMS AVE. #202 HUNTINGTON BEACH CA 92646 657-208-0890
Mosaic ImmunoEngineering Inc. (Filer) CIK: 0000836564 (see all company filings)

EIN.: 841070278 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-22182 | Film No.: 24942823
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)